Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"risperidone"

Slides: 1–12 of 46
Add to tray Remove from tray

Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders

Presentation: Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders
Keywords: CER | comparative effectiveness review
Add to tray Remove from tray

Key Question 1: Clinical Bottom Line — Benefits Associated With Medical Interventions

Presentation: Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders
Keywords: benefits | interventions | medical | strength of evidence | therapy | treatment | outcomes
Add to tray Remove from tray

Key Question 1: – Clinical Bottom Line: Harms Associated With Medical Interventions

Presentation: Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders
Keywords: outcomes | strength of evidence | treatment | therapy | interventions | medical | harms
Add to tray Remove from tray

Outcomes of Risperidone and Aripiprazole for Irritability

Presentation: Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders
Keywords: harms | interventions | medical | strength of evidence | therapy | treatment | outcomes
Add to tray Remove from tray

Outcomes of Risperidone and Aripiprazole for Hyperactivity/Noncompliance

Presentation: Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders
Keywords: harms | interventions | medical | strength of evidence | therapy | treatment | outcomes
Add to tray Remove from tray

Adverse Events Experienced by Patients Taking Risperidone and Aripiprazole

Presentation: Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders
Keywords: outcomes | strength of evidence | treatment | therapy | interventions | medical | harms
Add to tray Remove from tray

Note Regarding Possible Harms

Presentation: Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders
Keywords: outcomes | treatment | therapy | intervention | harm | medical | chelation
Add to tray Remove from tray

Future Research Needs

Presentation: Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders
Keywords: gaps in knowledge | research | summary | conclusion
Add to tray Remove from tray

Antipsychotics Approved for Pediatric Use: Second-Generation Antipsychotics

Presentation: First- and Second-Generation Antipsychotics for Children and Young Adults
Keywords: aripiprazole | atypical antipsychotics | first-generation antipsychotics | off-label | olanzapine | pediatrics | quetiapine | risperidone | second-generation antipsychotics | typical antipsychotics | antipsychotics
Add to tray Remove from tray

Efficacy of Second-Generation Antipsychotics: Placebo Comparisons, by Indication (1 of 3)

Presentation: First- and Second-Generation Antipsychotics for Children and Young Adults
Keywords: aripiprazole | atypical antipsychotics | bipolar disorder | first-generation antipsychotics | olanzapine | pediatrics | quetiapine | risperidone | second-generation antipsychotics | typical antipsychotics | ziprasidone | antipsychotics
Add to tray Remove from tray

Efficacy of Second-Generation Antipsychotics: Placebo Comparisons, by Indication (2 of 3)

Presentation: First- and Second-Generation Antipsychotics for Children and Young Adults
Keywords: antipsychotics | pediatrics | first-generation antipsychotics | second-generation antipsychotics | typical antipsychotics | atypical antipsychotics | schizophrenia | Tourette’s syndrome
Add to tray Remove from tray

Efficacy of Second-Generation Antipsychotics: Placebo Comparisons, by Indication (3 of 3)

Presentation: First- and Second-Generation Antipsychotics for Children and Young Adults
Keywords: antipsychotics | pediatrics | first-generation antipsychotics | second-generation antipsychotics | typical antipsychotics | atypical antipsychotics | pervasive developmental disorder | PDD | attention deficit hyperactivity disorder | ADHD | disruptive behavior disorder | DBD
Pages: [1] 2 3 4 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364